Sunday, November 19, 2017
 
 
News: Page (1) of 1 - 07/22/11 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
FDA: 2-fold death increase seen with heart drug
FDA warns of 2-fold death increase seen with Sanofi heart drug Multaq
By The Associated Press

WASHINGTON (AP) ' Federal health regulators are warning doctors that a heart drug from Sanofi was associated with fatal heart problems in a recently halted company study.

The Food and Drug Administration reported Thursday that Sanofi halted a trial of its drug Multaq after patients taking the drug showed a two-fold increase in heart attacks, stroke and death compared with patients taking placebo.

The study enrolled patients with a permanent heart condition known as atrial fibrillation which causes the heart's chambers to pump irregularly. The FDA approved the drug in 2009 for a temporary form of the condition. About 241,000 U.S. have received a prescription for the drug.



The FDA said it is still reviewing the trial results and advises patients taking Multaq to talk with their doctor.


Page: 1


 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines